UniProtKB/Swiss-Prot P07315: Variant p.Arg168Trp

Gamma-crystallin C
Gene: CRYGC
Feedback?

Variant information Variant position:

168 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Tryptophan (W) at position 168 (R168W, p.Arg168Trp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to large size and aromatic (W) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In CTRCT2; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs28931604 [ dbSNP | Ensembl ]

Sequence information Variant position:

168 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

174 The length of the canonical sequence.
Location on the sequence:

PQEYRRCQDWGAMDAKAGSL R RVVDLY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PQEYRRCQDWGAMDAKAGSLRRVVDLY

                              PQEYRRYHDWGAMDAKAGSLRRVVDLY

Rhesus macaque                PQEYRRCQDWGAMDAKAGSLRRVVDLY

Mouse                         PQEYRRFQDWGSVDAKAGSLRRVVDLY

Rat                           PQEYRRYHDWGAVDAKAGSLRRVVDLY

Bovine                        PQEYRRYQDWGAVDAKAGSLRRVVDLY

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 174	Gamma-crystallin C
Domain	129 – 171	Beta/gamma crystallin 'Greek key' 4
Beta strand	165 – 169

Literature citations
Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts.
Santhiya S.T.; Shyam Manohar M.; Rawlley D.; Vijayalakshmi P.; Namperumalsamy P.; Gopinath P.M.; Loester J.; Graw J.;
J. Med. Genet. 39:352-358(2002)
Cited for: VARIANT CTRCT2 TRP-168; VARIANT HIS-48; Crystallin gene mutations in Indian families with inherited pediatric cataract.
Devi R.R.; Yao W.; Vijayalakshmi P.; Sergeev Y.V.; Sundaresan P.; Hejtmancik J.F.;
Mol. Vis. 14:1157-1170(2008)
Cited for: VARIANT CTRCT2 TRP-168;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.